Monte Rosa Therapeutics Azioni (NASDAQ: GLUE)

Monte Rosa Therapeutics (NASDAQ:GLUE) Azioni

Monte Rosa Therapeutics

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics Inc

Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) has outperformed the market over the past 20 years by 3.94% on an annualized basis producing an average annual return of 12.1%. Currently, Check Point Software has a market capitalization of $24.29 billion. 
Buying $1000 In CHKP: If an investor had bought $1000 of CHKP stock 20 years ago, it would be worth $9,838.31 today based on a price of $220.87 for CHKP at the time of writing.
<h3>Check Point Software's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746661513_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

CHKP

Here's How Much $1000 Invested In Check Point Software 20 Years Ago Would Be Worth Today

GoDaddy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>) has outperformed the market over the past 10 years by 10.87% on an annualized basis producing an average annual return of 21.2%. Currently, GoDaddy has a market capitalization of $25.29 billion. 
Buying $100 In GDDY: If an investor had bought $100 of GDDY stock 10 years ago, it would be worth $713.05 today based on a price of $183.11 for GDDY at the time of writing.
<h3>GoDaddy's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746660611_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GDDY

Here's How Much You Would Have Made Owning GoDaddy Stock In The Last 10 Years

Amplitude (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPL#NASDAQ">AMPL</a>) reported quarterly sales of $79.95 million which beat the analyst consensus estimate of $79.75 million by 0.25 percent. This is a 10.09 percent increase over sales of $72.62 million the same period last year.

Earnings

Earnings Beats

AMPL

UPDATE: Amplitude Q1 Adj. EPS $0.00 Beats $(0.01) Est., Sales $79.95M Beat $79.75M Estimate

ACV Auctions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACVA#NASDAQ">ACVA</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.12) by 133.33 percent. This is a 3900 percent increase over earnings of $0.00 per share from the same period last year. The company reported quarterly sales of $182.70 million which beat the analyst consensus estimate of $182.07 million by 0.34 percent. This is a 25.40 percent increase over sales of $145.69 million the same period last year.

ACVA

UPDATE: ACV Auctions Q1 Adj. EPS $0.04 Beats $(0.12) Estimate, Sales $182.70M Beat $182.07M Estimate

<a href="https://www.benzinga.com/personal-finance/25/02/43718032/warren-buffett-was-asked-how-a-regular-person-gets-rich-he-detailed-exactly-how-hed-make-30-billion-starting-over-with-only-10000">Warren Buffett</a> has spent decades sizing up the world's sharpest business minds. He's outlasted rivals, spotted winners early, and—let's be honest—become a billionaire many times over doing it. But even Buffett knows when it's time to tip his hat.
And for him, nobody earns that gesture quite like Jeff Bezos.
Buffett has openly admired fellow top-ranking billionaire Bezos for years. While he didn't invest in Amazon early—something he's joked about regretting—Buffett never underestimated Bezos' rare genius.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
In a <a href="https://www.cnbc.com/2016/05/02/warren-buffett-says-hes-in-awe-of-jeff-bezos-genius.html">2016 CNBC interview</a>, Buffett said, "There are certain people you do not want to try to beat at their own game and certainly Jeff Bezos would be No. 1."
What set Bezos apart? It wasn't a shiny new invention or some scientific breakthrough. "It isn't that [Bezos has] gotten some breakthrough or found some molecule or come up with some incredible invention," Buffett explained. Instead, Bezos had "shown an amazing talent" by taking everyday things people already bought and "figuring out a way to make people happier buying those products."
"That's remarkable," Buffett added.
By 2017, Buffett's admiration only deepened. Speaking again to CNBC, he called Bezos "the most remarkable business person of our age."&nbsp;
What amazed him most was Bezos' ability to dominate two wildly different industries at once: online retail and cloud computing. "I've never seen a guy <a href="https://www.benzinga.com/news/25/04/45074825/jeff-bezos-says-an-employee-looked-at-me-like-i-was-the-stupidest-person-theyd-ever-seen-then-offered-a-simple-idea-that-changed-amazon">succeed in two businesses almost simultaneously</a> that are really quite divergent in terms of customers and all the operations," Buffett said. "I can't think of another example like it."
Trending: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Buffett even admitted he underestimated Amazon's potential. "<a href="https://www.benzinga.com/startups/24/09/40693497/warren-buffett-admitted-he-was-too-dumb-and-an-idiot-for-not-investing-in-amazon-early-on-but-finall">I was too dumb to realize what was going to happen</a>," he said, calling himself out for missing the early boat. "I underestimated the brilliance and the execution."
Eventually, Berkshire Hathaway got on board. The company purchased its first Amazon shares in early 2019. As of May 2025, Berkshire holds about 10 million Amazon shares—worth roughly $2.19 billion.&nbsp;
Buffett clarified that the buy wasn't his idea but came from one of Berkshire's younger investment managers, a sign of the firm's evolving approach toward growth and tech stocks.
So while Buffett may have arrived late to Amazon's meteoric rise, he backed the man he calls unbeatable—and the most remarkable business mind of his time.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.</li>
</ul>
Image: Shutterstock

Personal Finance

'Jeff Bezos Would Be No. 1' — Warren Buffett Says Some People You Shouldn't Even Try to Beat, Praises Him As 'Most Remarkable Business Person'

BGSF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGSF#NYSE">BGSF</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.11) by 145.45 percent. This is a 28.57 percent decrease over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $63.23 million which missed the analyst consensus estimate of $65.25 million by 3.09 percent. This is a 8.04 percent decrease over sales of $68.77 million the same period last year.

Earnings Misses

BGSF

CORRECTION: BGSF Q1 Adj. EPS $0.05 Beats $(0.11) Estimate, Sales $63.23M Miss $65.25M Estimate

Goodyear Tire &amp; Rubber (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 140 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $4.25 billion which missed the analyst consensus estimate of $4.41 billion by 3.56 percent. This is a 6.26 percent decrease over sales of $4.54 billion the same period last year.

CORRECTION: Goodyear Tire & Rubber Q1 Adj. EPS $(0.04) Misses $(0.03) Estimate, Sales $4.25B Miss $4.41B Estimate

Myomo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYO#AMEX">MYO</a>) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $9.83 million which missed the analyst consensus estimate of $10.91 million by 9.91 percent. This is a 161.93 percent increase over sales of $3.75 million the same period last year.

CORRECTION: Myomo Q1 EPS $(0.08) Misses $(0.06) Estimate, Sales $9.83M Miss $10.91M Estimate

Vertiv Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) has outperformed the market over the past 5 years by 38.18% on an annualized basis producing an average annual return of 52.56%. Currently, Vertiv Holdings has a market capitalization of $36.20 billion. 
Buying $100 In VRT: If an investor had bought $100 of VRT stock 5 years ago, it would be worth $827.73 today based on a price of $95.00 for VRT at the time of writing.
<h3>Vertiv Holdings's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746659713_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Vertiv Holdings 5 Years Ago Would Be Worth Today

TBBB

UPDATE: BBB Foods Q1 EPS $(0.04) Misses $0.06 Estimate, Sales $836.87M Beat $799.73M Estimate

Rep. Marjorie Taylor Greene (R-Ga.) has been actively buying stocks in 2025, including transactions that may have been perfectly timed<a href="https://www.benzinga.com/politics/25/04/44852406/marjorie-taylor-greene-brushes-off-stock-buying-criticism-says-portfolio-manager-bought-the-dip"> during a market dip.</a>
Here's the latest transactions made by the congresswoman in early May.
What Happened: Greene was ranked as the 24th best-performing member of Congress based on their trades in 2024. The Congresswoman gained 30.2% for the year, <a href="https://www.benzinga.com/25/01/42860759/10-best-stock-traders-in-congress-in-2024-where-do-nancy-pelosi-pete-sessions-susan-collins-marjorie-taylor-greene-rank">outperforming the S&amp;P 500 </a>gain of 24.9%.
With new trades placed throughout the early months of 2025, Greene could see huge returns again during the year.
Here are her most recent trades made on May 5, as shown on the <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent050725">Benzinga Government Trades page</a>. All purchases made were listed as between $1,001 to $15,000 unless otherwise indicated.
<ul>
<li>Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)</li>
<li>AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>)</li>
<li>Adobe Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>)</li>
<li>Applied Materials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>)</li>
<li>Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)</li>
<li>Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</li>
<li>American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>)</li>
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>)</li>
<li>Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>)</li>
<li>BHP Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>)</li>
<li>BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>)</li>
<li>Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>)</li>
<li>Blackstone Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>)</li>
<li>Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>)</li>
<li>Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>)</li>
<li>Cummins Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>)</li>
<li>Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>)</li>
<li>Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>)</li>
<li>Digital Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>)</li>
<li>Duke Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>)</li>
<li>Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>)</li>
<li>FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>)</li>
<li>Frontline PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>)</li>
<li>Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>): two separate purchases of $1,001 to $15,000</li>
<li>Corning Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>)</li>
<li>Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)</li>
<li>Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>)</li>
<li>Home Depot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>)</li>
<li>The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>)</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)</li>
<li>Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>)</li>
<li>JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>)</li>
<li>Kinder Morgan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>)</li>
<li>Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)</li>
<li>MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>)</li>
<li>Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)</li>
<li>Merck Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>)</li>
<li>Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>)</li>
<li>Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)</li>
<li>NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>)</li>
<li>ServiceNow Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NASDAQ">NOW</a>)</li>
<li>Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>): two separate purchases of $1,001 to $15,000</li>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</li>
<li>Old Dominion Freight Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>)</li>
<li>Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>): two separate purchases of $1,001 to $15,000</li>
<li>Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>)</li>
<li>Paychex Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>)</li>
<li>Impinj Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>)</li>
<li>Qualcomm Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>)</li>
<li>Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>)</li>
<li>Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>)</li>
<li>Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</li>
<li>United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>)</li>
<li>Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>)</li>
<li>Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>)</li>
</ul>
In total, that's more than 50 different stocks bought and disclosed by Greene in the latest filing. Based on the purchase range of $1,001 to $15,000, this would make the transaction range over $50,000 and up to more than $800,000.
Read Also: <a href="https://www.benzinga.com/politics/25/04/45077654/bill-named-after-nancy-pelosi-could-ban-congress-members-from-trading-stocks-what-you-need-to-know-about-the-pelosi-act">Bill Named After Nancy Pelosi Could Ban Congress Members From Trading Stocks: What You Need To Know About The &#8216;PELOSI&#8217; Act</a>
Why It's Important: Members of Congress are allowed to buy and sell stocks as long as they properly disclose the transaction.
The process has drawn scrutiny from the public and retail investors as members of Congress could have inside information and time their trades accordingly. Committee assignments in particular, often draw red flags from investors.
Greene serves on the House Committee on Oversight and Accountability and the House Committee on Homeland Security with several subcommittee appointments. The congresswoman's past trade in technology and cybersecurity stocks has drawn attention with her role within Homeland Security.
Greene&#8217;s past trades of Palantir Technologies and a<a href="https://www.benzinga.com/25/03/44255172/marjorie-taylor-greene-buys-more-bitcoin-etf-shares-ahead-of-trumps-strategic-reserve-executive-order"> Bitcoin ETF </a>have drawn criticism along with the timing of her trades, as she is a close ally to President Donald Trump. 
When asked previously about buying stocks earlier this year that soared days later after Trump announced a pause to tariffs, Greene<a href="https://www.benzinga.com/politics/25/04/44852406/marjorie-taylor-greene-brushes-off-stock-buying-criticism-says-portfolio-manager-bought-the-dip"> brushed aside the criticism.</a>
&#8220;I think that criticism is laughable. President Trump has been talking about tariffs for decades,&#8221; Greene told reporters when asked about the trades at a recent town hall event in Georgia in a clip <a href="https://x.com/unusual_whales/status/1912456434081480777" target="_blank" rel="noreferrer noopener">shared </a>by Unusual Whales. The congresswoman used the opportunity to boast about her stock performance, which ranked her as one of the top trading members of Congress in 2024.
&#8220;I don&#8217;t place my buys and sells," Greene said, citing an agreement she has with her portfolio manager, who handles all the buying and selling of stocks. &#8220;He did a great job. Guess what he did. He bought the dip. And that&#8217;s what anybody that has financial sense does."
Greene also said her portfolio manager did not have inside information, everything was public and a potential tariff pause wasn&#8217;t a secret.
Sen. Josh Hawley (R-Mo.) has reintroduced legislation that would ban members of Congress from trading or holding individual stocks.
The bill is known as the Preventing Elected Leaders from Owning Securities and Investments Act, or PELOSI Act based on the first letter of each of the main words. The name takes aim at the congresswoman and former Speaker of the House Nancy Pelosi (D-Calif.).  
&#8220;Members of Congress should be fighting for the people they were elected to serve — not day trading at the expense of their constituents,&#8221; Hawley&nbsp;<a href="https://www.hawley.senate.gov/hawley-reintroduces-pelosi-act-to-ban-congress-from-trading-stocks/" target="_blank" rel="noreferrer noopener">said</a>. &#8220;Americans have seen politician after politician turn a profit using information not available to the general public.&#8221;
Hawley said the bill will help &#8220;restore Americans&#8217; trust in our nation&#8217;s legislative body.&#8221;
Hawley&#8217;s bill is being reintroduced as President&nbsp;Donald Trump&nbsp;<a href="https://time.com/7280114/donald-trump-2025-interview-transcript/" target="_blank" rel="noreferrer noopener">said&nbsp;</a>he would support such a ban.
&#8220;Well, I watched Nancy Pelosi get rich through insider information, and I would be okay with it. If they send it to me, I would do it,&#8221; Trump told TIME.
Trump said he would sign the ban if the bill passes Congress.
While Pelosi makes headlines for her trades, it&#8217;s important to remember that<a href="https://www.benzinga.com/politics/25/04/44852406/marjorie-taylor-greene-brushes-off-stock-buying-criticism-says-portfolio-manager-bought-the-dip" target="_blank" rel="noreferrer noopener">&nbsp;it is both Republican</a>&nbsp;and Democratic members of Congress who are profiting from buying and selling stocks and options while in office, with some trades coming with questionable timing or having a connection to committees they serve on.
In 2024, a list of the top-performing traders in Congress included six Republicans and four Democrats.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent050725">Get Tips On What They Bought And Sold With Our Easy-to-Use Tool</a></li>
</ul>
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent050725"><img loading="lazy" decoding="async" width="1024" height="330" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07181256/Picture1-1-1024x330.png" alt="" class="wp-image-906796" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07181256/Picture1-1-1024x330.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07181256/Picture1-1-300x97.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07181256/Picture1-1-768x248.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07181256/Picture1-1.png 1430w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Photo: Shutterstock

Government

Politics

AAPL

ABBV

ADBE

AMAT

AMZN

DELL

GILD

GOOG

INTC

MELI

MSFT

NVDA

ODFL

PANW

PAYX

QCOM

SBUX

SCHW

TSLA

Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought

The One Group Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0.14) by 200 percent. This is a 800 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $211.13 million which beat the analyst consensus estimate of $202.97 million by 4.02 percent. This is a 148.40 percent increase over sales of $85.00 million the same period last year.

STKS

CORRECTION: The One Group Hospitality Q1 Adj. EPS $0.14 Beats $(0.14) Estimate, Sales $211.13M Beat $202.97M Estimate

Today the Company announces a ten-cent special dividend.
The dividend will be paid May 28th to shareholders of record on May 19th
Mr. Dan O'Brien, CEO, states, "We are pleased that our current financial condition and expectations of continued profitability allows us to dividend profits to shareholders at this time. However, this is a special dividend; not a regular dividend." Mr. O'Brien continues, "The FSI Board and management will continue to monitor retained earnings and capital needs in order to execute the goals of growing the Company and declaring dividends when appropriate."

Dividends

Flexible Solutions International Announces $0.10 Special Dividend

A-Mark Precious Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRK#NASDAQ">AMRK</a>) reported quarterly earnings of $0.24 per share which missed the analyst consensus estimate of $0.59 by 59.32 percent. This is a 14.29 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $3.01 billion which beat the analyst consensus estimate of $2.80 billion by 7.49 percent. This is a 15.30 percent increase over sales of $2.61 billion the same period last year.

AMRK

UPDATE: A-Mark Precious Metals Q3 Adj. EPS $0.24 Misses $0.59 Estimate, Sales $3.01B Beat $2.80B Estimate

Texas Pacific Land (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPL#NYSE">TPL</a>) has outperformed the market over the past 5 years by 34.72% on an annualized basis producing an average annual return of 49.1%. Currently, Texas Pacific Land has a market capitalization of $30.88 billion. 
Buying $1000 In TPL: If an investor had bought $1000 of TPL stock 5 years ago, it would be worth $7,367.71 today based on a price of $1343.38 for TPL at the time of writing.
<h3>Texas Pacific Land's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746658816_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Texas Pacific Land 5 Years Ago Would Be Worth This Much Today

Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock price dropped on Wednesday after the company reported worse-than-expected <a target="_blank" href="https://www.benzinga.com/25/05/45245696/smci-issues-strong-q4-revenue-outlook-expects-nvidias-blackwell-to-fuel-growth" rel="noreferrer noopener">third-quarter financial results</a> on Tuesday.
Wall Street analysts rerated the stock.
<ul>
<li>Needham analyst Quinn Bolton reinstated Super Micro Computer with a Buy and a <a href="https://www.benzinga.com/quote/SMCI/analyst-ratings" target="_blank" rel="noreferrer noopener">$39 price target</a>.</li>
<li>Wedbush analyst Matt Bryson reiterated Super Micro Computer with a Neutral rating and lowered his price target to $30 (from $40).</li>
<li>JP Morgan analyst Samik Chatterjee gave Super Micro Computer a neutral rating and a price target of $35 (down from $36).</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/04/45113405/super-micro-faces-cautious-analyst-view-amid-shifting-customer-demand-and-declining-margins" rel="noreferrer noopener">Super Micro Faces Cautious Analyst View Amid Shifting Customer Demand And Declining Margins</a>
Needham: Super Micro posted third-quarter revenue of $4.6 billion, -19.0% Q/Q and +19.5% Y/Y, in line with the company&#8217;s preliminary announcement but well below previous guidance (midpoint at $5.5 billion). The weakness was due to customers waiting and evaluating next-gen AI platforms (Blackwell), which led to delayed commitments.
The quarterly adjusted gross margin came in at 9.7%, below the Street&#8217;s 10.1% estimate. Margins were negatively affected by higher inventory reserve charges on older Hopper systems, lower volume, and accelerated new-product costs.
The quarterly adjusted EPS was $0.31, which is in line with the preliminary announcement but well below the previous guidance (midpoint at $0.54). The miss was driven by lower revenue and margins.
The company guided fourth-quarter revenue to $6.0 billion at the midpoint, +30.4% Q/Q and +13.0% Y/Y, well below Bolton&#8217;s estimate of $7.0 billion and the Street&#8217;s estimate of $6.59 billion.
The quarterly adjusted EPS should come in at $0.45 at the midpoint, below Bolton&#8217;s prior estimate of $0.74 and the Street&#8217;s estimate of $0.64.
Super Micro has been at the forefront of liquid cooling technology, and the announcement of DLC-2 further solidifies its leadership.
Management highlighted product transitions from Hopper to Blackwell and tariff uncertainty as key contributors to near-term weakness.
Despite near-term headwinds, Bolton became incrementally more positive for the company as it filed its 2024 10-K and 2025 10-Qs and added to its management bench. The analyst found the valuation extremely attractive for a company targeting AI/HPC end markets and being at the forefront of liquid-cooled data centers.
Wedbush: Bryson noted that GB200 and B200 availability was limited early in the quarter, with initial parts primarily shipping to select Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) accounts.
This situation has been largely rectified, supporting a rebound in the next quarter. Super Micro is effectively guiding for a slight dip in gross margins on older products that it likely needs to discount to sell. The analyst noted OEMs were pushed to take Hopper, given B200 shortages.
He said Super Micro&#8217;s choice to step away from guiding for a gross margin rebound was properly pragmatic, particularly given uncertainty around the US administration&#8217;s next steps. In the intermediate to longer term, Bryson expects better pricing and margins on initial B200 servers in light of the tight supply. Super Micro&#8217;s diversified manufacturing presence could allow it to better navigate US policy than some of its peers.
Bryson projected fourth-quarter revenue of $5.95 billion and adjusted EPS of $0.45.
JP Morgan: Super Micro posted results primarily in line with the pre-announcement that had represented a roughly $900 million miss on revenue and an approximately 200 bps+ miss on gross margins to the earlier stated outlook for the fiscal third quarter.
With the company pre-announcement implying that the miss was led by one-off factors like customer platform decisions and inventory write-downs, expectations were for a sharper earnings rebound through revenue and margins.
However, the update from the company about fiscal fourth-quarter expectations highlights customer push-out of deployments in fiscal third-quarter was not limited to one or two customers and represents an ongoing challenge about customers deciding between multiple platforms as well as data center readiness to accept shipments as planned.
Lower cost inventory-related headwinds to gross margins are still not entirely behind the company, with up to 100 bps of gross margin impact in the fiscal fourth quarter, driving guidance for ~10% gross margins.
There remains the potential for further risks to gross margin if the company does not manage to sell its Hopper inventory. On the business drivers, the company continued to highlight leadership relative to the time to market for the latest technology-based servers in the high-growth AI servers market, as well as the expected launch of Data Canter Building Block Solutions (DCBBS), featuring their next-generation Direct Liquid Cooling (DLC 2.0) capabilities.
Chatterjee projected fourth-quarter revenue of $6 billion and adjusted EPS of $0.44.
Price Action: SMCI stock closed at $32.48 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/05/45235394/nvidia-broadcom-lead-fund-manager-buys-even-as-semiconductor-sector-cools-analysts" target="_blank" rel="noreferrer noopener">Nvidia, Broadcom Lead Fund Manager Buys Even As Semiconductor Sector Cools: Analysts</a></li>
</ul>
Photo courtesy: CryptoFX via Shutterstock

Analyst Color

Price Target

Reiteration

Analyst Ratings

Tech

SMCI

Super Micro Impacted By AI Server Delays And Nvidia Supply Limits, Analysts Lower Forecast

Excelerate Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EE#NYSE">EE</a>) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.39 by 25.64 percent. This is a 104.17 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $315.09 million which beat the analyst consensus estimate of $207.87 million by 51.58 percent. This is a 57.47 percent increase over sales of $200.10 million the same period last year.

UPDATE: Excelerate Energy Q1 Adj. EPS $0.49 Beats $0.39 Estimate, Sales $315.09M Beat $207.87M Estimate

WIIM

QVCGB

QVCGB stock has given up its prior loss. QVC Group shares were trading lower after the company reported a year-over-year decrease in Q1 EPS and revenue results.

Core Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.10) by 360 percent. This is a 342.11 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $79.53 million which missed the analyst consensus estimate of $88.85 million by 10.50 percent. This is a 55.64 percent decrease over sales of $179.29 million the same period last year.

Core Scientific, Inc. - Class A Common Stock

CORZ

Core Scientific Q1 Adj. EPS $(0.46) Misses $(0.10) Estimate, Sales $79.53M Miss $88.85M Estimate

J.P. Morgan analyst Ken Goldman on Tuesday assigned a Neutral rating on the shares of WK Kellogg Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLG#NYSE">KLG</a>) with a price forecast of $19.00.
The company reported <a target="_blank" href="https://www.benzinga.com/25/05/45233622/wk-kellogg-misses-q1-earnings-flags-modest-tariff-impact-from-raw-material-sourcing" rel="noreferrer noopener">first-quarter earnings per share </a>of 20 cents, missing the street view of 34 cents. Quarterly sales of $663 million missed the analyst consensus estimate of $679.49 million.
KLG revised its 2025 outlook, now expecting organic net sales to decline 2.0% to 3.0%, and adjusted EBITDA to be flat or down 2.0%, versus previous forecasts of milder declines and EBITDA growth.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/restaurants/25/04/45021992/us-restaurants-face-growth-hurdles-as-macro-headwinds-mount-says-analyst" rel="noreferrer noopener">US Restaurants Face Growth Hurdles As Macro Headwinds Mount, Says Analyst</a>
The outlook reflects modest tariff impacts on raw materials, assuming continued trade exemptions with Canada and Mexico, though the company warned future tariff changes could further affect results.
On the positive side, the analyst sees significant potential for margin expansion and believes the stock's current low valuation could help support its price.
However, the analyst remains cautious about the company's projections for EBITDA margin gains, especially given weak sales trends.
The long-term decline in the cereal market poses structural challenges, and upcoming restructuring and capital expenditures will strain cash flow, noted the analyst.
The analyst said KLG shares should trade at a discount compared to larger packaged food companies due to ongoing difficulties in the cereal category, substantial upcoming spending on capital projects and restructuring, and the company's smaller scale.
Price Action: KLG shares closed lower by 3.90% to $17.23 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/restaurants/25/04/44907247/restaurant-sector-q1-volatilty-from-weather-inflation-analyst-lowers-price-targets" target="_blank" rel="noreferrer noopener">Restaurant Sector Q1 Volatility From Weather, Inflation — Analyst Lowers Price Targets</a></li>
</ul>
Photo by JHVEPhoto via Shutterstock

Movers

General

Long-Term Decline In Cereal Market Poses Structural Challenges For Kellogg, Analyst Says

Health Care

Press Releases

Monte Rosa Therapeutics Provides Development Progress Update for Ongoing MRT-2359 Phase 1/2 Study in Patients with MYC-driven Solid Tumors

Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders

Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degraders to Treat HR-positive/HER2-negative Breast Cancer

Management

Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors

Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025

Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025

Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-positive/HER2-negative Breast Cancer

Comments

Monte Rosa Therapeutics

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO